Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings (Q21144607)

From Wikidata

Jump to navigation Jump to search

scientific article

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings

Language	Label	Description	Also known as
English	Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings	scientific article	Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings

Statements

scholarly article

0 references

Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings (English)

0 references

0 references

anti-retroviral agent

0 references

Beatriz Grinsztejn

7

object named as

Beatriz Grinsztejn

author given names

Beatriz

author last names

Grinsztejn

1 reference

PubMed publication ID

16 August 2022

Nagalingeswaran Kumarasamy

3

object named as

N Kumarasamy

author given names

N

author last names

Kumarasamy

1 reference

PubMed publication ID

16 August 2022

Cynthia Firnhaber

6

object named as

Cynthia Firnhaber

author given names

Cynthia

author last names

Firnhaber

1 reference

PubMed publication ID

16 August 2022

Thomas B. Campbell

1

object named as

Thomas B Campbell

author given names

Thomas B

author last names

Campbell

1 reference

PubMed publication ID

16 August 2022

Robert T. Schooley

24

object named as

Robert T Schooley

author given names

Robert T

author last names

Schooley

1 reference

PubMed publication ID

16 August 2022

Timothy P Flanigan

4

object named as

Timothy Flanigan

author given names

Timothy

author last names

Flanigan

1 reference

PubMed publication ID

16 August 2022

Mina C Hosseinipour

8

object named as

Mina C Hosseinipour

author given names

Mina C

author last names

Hosseinipour

1 reference

PubMed publication ID

16 August 2022

Srikanth Tripathy

15

author given names

Srikanth

author last names

Tripathy

object named as

Srikanth Tripathy

1 reference

PubMed publication ID

16 August 2022

Cynthia Riviere

11

author given names

Cynthia

author last names

Riviere

object named as

Cynthia Riviere

1 reference

PubMed publication ID

16 August 2022

Johnstone J Kumwenda

9

author given names

Johnstone

author last names

Kumwenda

object named as

Johnstone Kumwenda

1 reference

PubMed publication ID

16 August 2022

26

author given names

James Gita

author last names

Hakim

object named as

James Gita Hakim

1 reference

PubMed publication ID

16 August 2022

Marineide Gonçalves de Melo

13

author given names

Marineide

author last names

Melo

object named as

Marineide Melo

1 reference

PubMed publication ID

16 August 2022

Laura M Smeaton

2

author given names

Laura M

author last names

Smeaton

object named as

Laura M Smeaton

1 reference

PubMed publication ID

16 August 2022

10

author given names

Umesh

author last names

Lalloo

object named as

Umesh Lalloo

1 reference

PubMed publication ID

16 August 2022

Khuanchai Supparatpinyo

14

author given names

Khuanchai

author last names

Supparatpinyo

object named as

Khuanchai Supparatpinyo

1 reference

PubMed publication ID

16 August 2022

Karin L Klingman

5

author given names

Karin L

author last names

Klingman

object named as

Karin L Klingman

1 reference

PubMed publication ID

16 August 2022

17

author given names

Apsara

author last names

Nair

object named as

Apsara Nair

1 reference

PubMed publication ID

16 August 2022

18

author given names

Ann

author last names

Walawander

object named as

Ann Walawander

1 reference

PubMed publication ID

16 August 2022

Victor De Gruttola

25

author given names

Victor

author last names

De Gruttola

object named as

Victor De Gruttola

1 reference

PubMed publication ID

16 August 2022

author name string

Jorge Sanchez

12

author given names

Jorge

author last names

Sanchez

1 reference

PubMed publication ID

16 August 2022

Ana I Martinez

16

author given names

Ana I

author last names

Martinez

1 reference

PubMed publication ID

16 August 2022

Laura Moran

19

author given names

Laura

author last names

Moran

1 reference

PubMed publication ID

16 August 2022

Yun Chen

20

author given names

Yun

author last names

Chen

1 reference

PubMed publication ID

16 August 2022

Wendy Snowden

21

author given names

Wendy

author last names

Snowden

1 reference

PubMed publication ID

16 August 2022

James F Rooney

22

author given names

James F

author last names

Rooney

1 reference

PubMed publication ID

16 August 2022

Jonathan Uy

23

author given names

Jonathan

author last names

Uy

1 reference

PubMed publication ID

16 August 2022

language of work or name

0 references

publication date

2012

0 references

0 references

9

0 references

8

0 references

e1001290

0 references

copyright license

Creative Commons CC0 License

14 August 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

7 April 2017

Infant outcomes after maternal antiretroviral exposure in resource-limited settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

12 September 2017

Sex differences in antiretroviral therapy-associated intolerance and adverse events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

12 September 2017

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

12 September 2017

Adverse events from drug therapy for human immunodeficiency virus disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

12 September 2017

Neutropenia and bacterial infection in acquired immunodeficiency syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

12 September 2017

Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

30 May 2018

Sex-related differences in the pharmacokinetics of once-daily saquinavir soft-gelatin capsules boosted with low-dose ritonavir in patients infected with human immunodeficiency virus type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

30 May 2018

Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

30 May 2018

Better mind the gap: addressing the shortage of HIV-positive women in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Efficacy and safety of atazanavir, with or without ritonavir, as part of once-daily highly active antiretroviral therapy regimens in antiretroviral-naive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Combining dependent tests for linkage or association across multiple phenotypic traits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Differences between women and men in adverse events and CD4 responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Human immunodeficiency virus disease-related neutropenia and the risk of hospitalization for bacterial infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419182

29 November 2018

Neutropenia in patients with HIV infection: a case control study in a cohort of 1403 patients between 1982 and 1993

1 reference

https://pubmed.ncbi.nlm.nih.gov/22936892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22936892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of saquinavir with atazanavir or low-dose ritonavir administered once daily (ASPIRE I) or twice daily (ASPIRE II) in seronegative volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22936892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment 2.0: catalysing the next phase of scale-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22936892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PMED.1001290

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21144607&oldid=2212215502"